Nexus AG is a healthcare software company based in Donaueschingen, Germany. It offers solutions for managing and optimizing healthcare facilities.

UBS Group AG has increased its stake in Nexus AG, now holding 5.42% of the voting rights, up from the previous 3.20%. This change will take effect on December 9, 2024, and is expected to impact the company's governance structure, shareholder dynamics, and strategic decision-making.

Nexus AG's stock is actively traded on German exchanges, including Frankfurt, Berlin, and Munich. The company has recorded a year-to-date price performance of 18.26% and an average trading volume of 97,956 shares. Its current market capitalization is €1.19 billion, and it has a technical sentiment consensus rating of "Sell."